SCHEMBL1696199

SCHEMBL1696199

C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2248044 0.93 ESR1 (0.39) ESR1ESR2
SCHEMBL18125 0.88 ESR1 (0.39) ESR1ESR2
SCHEMBL121414 0.83 ESR1 (0.42) ESR1ESR2
SCHEMBL6275201 0.82 ESR1 (0.35) ESR1ESR2
SCHEMBL18094256 0.82 ESR1 (0.35) ESR1ESR2
SCHEMBL15277333 0.82 ESR1 (0.35) ESR1ESR2
SCHEMBL2488828 0.80 ESR1 (0.34) ESR1ESR2
SCHEMBL18179380 0.80 ESR1 (0.34) ESR1ESR2
SCHEMBL30003086 0.78 ESR1 (0.33) ESR1ESR2
SCHEMBL13621387 0.78 ESR1 (0.39) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620068-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2006-02-01 EP claimed
WO-2004087077-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2004-10-14 WO claimed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US claimed
WO-2025149436-A1 W/O EMULSION COMPRISING A VOLATILE ALKANE, A NON VOLATILE MIXTURE OF C15 C19 ALKANES, AN ACYCLIC VOLATILE SILICONE OIL, A HYDROPHOBIC SILICA AEROGEL AND A SILICONE EMULSIFIER L'OREAL (FR) 2025-07-17 WO disclosed
EP-3558222-B1 WATER-IN-OIL EMULSION COMPRISING A PARTICULAR EMULSIFYING SYSTEM, A LIPOPHILIC CLAY, AND AN ORGANOPOLYSILOXANE ELASTOMER POWDER COATED WITH A SILICONE RESIN OREAL (FR) 2024-04-03 EP disclosed
EP-3558238-B1 COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL OREAL (FR) 2023-08-23 EP disclosed
US-11376205-B2 Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt L'OREAL (FR) 2022-07-05 US disclosed
CN-110099662-B Water-in-oil emulsion comprising a specific emulsifying system, a lipophilic clay and a silicone resin-coated organopolysiloxane elastomer powder 莱雅公司 2022-04-26 CN disclosed
EP-3558216-B1 WATER-IN-OIL EMULSION CONTAINING BAICALIN, A XANTHINE BASE, A VITAMIN B3, AND A POLYVALENT METAL CATION SALT L'ORÉAL (FR) 2020-09-16 EP disclosed
US-20200085723-A1 COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID beta,beta-DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL L'OREAL (FR) 2020-03-19 US disclosed
EP-3558216-A1 WATER-IN-OIL EMULSION CONTAINING BAICALIN, A XANTHINE BASE, A VITAMIN B3, AND A POLYVALENT METAL CATION SALT L'Oréal (FR) 2019-10-30 EP disclosed
WO-2011147696-A1 COSMETIC COMPOSITION COMPRISING AN OIL AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2011-12-01 WO disclosed
WO-2011148327-A1 COSMETIC COMPOSITION BASED ON A SUPRAMOLECULAR POLYMER AND AN ABSORBENT FILLER L'OREAL (FR) 2011-12-01 WO disclosed
WO-2011147697-A1 COSMETIC COMPOSITION COMPRISING A POLYSILOXANE AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2011-12-01 WO disclosed
EP-2380556-A1 Cosmetic composition comprising a volatile fatty phase L'Oréal (FR) 2011-10-26 EP disclosed
US-20090074689-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL S.A. 2009-03-19 US disclosed
WO-2006013413-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE LINEAR ALKYLTRISILOXANE L'OREAL (FR) 2006-02-09 WO disclosed
EP-1620068-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2006-02-01 EP disclosed
WO-2004087077-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2004-10-14 WO disclosed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11376205-B2 Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt KRT18, BROX, S100B ESR1 4223/4885ESR2 4346/4885
US-20200085723-A1 COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID beta,beta-DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL KRT18, CUTA, SKP1 ESR1 3821/4885ESR2 3585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.